BC-CfE’s CHIWOS researchers examine pregnancy intentions among women living with HIV

The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS) prioritizes community-based research with a heavy focus on increasing the meaningful involvement of people living with HIV/AIDS in research, particularly women.

While it is not widely known, it is nonetheless true that women living with HIV who are on antiretroviral treatment with an undetectable HIV viral load can become pregnant and have children with no risk of HIV transmission to their sexual partners and an extremely low risk of transmission to infants.

CHIWOS researchers, some of whom work at the BC-CfE, were aware that there was poor understanding of contemporary pregnancy intentions of women living with HIV in Canada or whether intentions predict eventual pregnancy. A new research article on the topic was recently published, titled, “Patterns of changing pregnancy intentions among women living with HIV in Canada”.

Data from the CHIWOS study has shown that, among women living with HIV of reproductive age in Canada, “60% have never discussed their reproductive goals with a healthcare provider since being diagnosed with HIV. Additionally, uptake of effective contraceptive methods among women living with HIV who report wanting to avoid pregnancy is low, and the range of contraceptive methods used is more narrow compared to HIV negative women, underscoring the need and opportunity to better understand and address the sexual and reproductive health needs of women living with HIV.”

The objectives of the recently published study were to measure and compare the pregnancy intentions of women living with HIV in Canada over time and to investigate the relationship between pregnancy intention within the study’s survey windows and subsequent pregnancies.

The study used longitudinal survey data from CHIWOS to measure and compare pregnancy intentions, which were categorized as either yes, no, or unsure. Intentions were measured at a baseline starting point, then at 18-month and 36-month follow-ups from 2013 to 2018 among women living with HIV of reproductive age.

Researchers observed diverse and dynamic pregnancy intentions over the 36-month follow-up period, as more than one-quarter of women changed their pregnancy intention over 18-months, and 42% did so over 36months.

These findings highlight that women living with HIV have a diverse range of pregnancy intentions that change over time. Dr. Angela Kaida is an Associate Professor at Simon Fraser University’s Faculty of Sciences and Canada Research Chair Tier II in Global Perspectives in HIV and Sexual and Reproductive Health. Dr. Kaida is a frequent collaborator with the BC-CfE and one of the study’s authors. She shared that the work, “provides a crucial understanding of both the dynamic property of pregnancy intentions and the social contexts that influence the relationship between women’s intentions and their reality.”

The CHIWOS team has developed toolkits and clinical guidelines to support women living with HIV and their providers with pregnancy and parenting goals in the context of HIV.

These study findings highlight the need for widespread dissemination of these tools alongside the promotion of open, non-stigmatizing, and, importantly, ongoing discussions about reproductive goals by, with, and for women living with HIV across the lifecourse.

– Dr. Kaida

Share the Post:
Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)